Peritoneal Dialysis Versus Haemodialysis

N/ACompletedNCT00752583

University Hospital, Ghent25 enrolled

Overview

Study in order to quantify toxin removal during dialysis

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

Conditions

Hemodialysis

Interventions

Peritoneal dialysisPROCEDURE

Blood, urine and dialysate sampling

HaemodialysisPROCEDURE

Blood, urine and dialysate sampling

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Substudy 1: includes new starting dialysis patients on peritoneal dialysis PD or haemodialysis HD * Substudy 2: stabile haemodialysis patients and peritoneal dialysis patients. Patients will be matched for gender, time on dialysis, diabetes, renal function at the start of dialysis. * Substudy 3: patients on CAPD (continuous ambulant PD) or CCPD (continuous cyclic PD).

Locations (1)

University Hospital Ghent

Ghent, Belgium

Outcomes

Primary Outcomes

Registration of toxin removal efficiency

Time frame: After 1 week and after 1, 3, 6, 9, 12, 18 and 24 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.